logo
  • Home
  • About Us
  • Cognition
  • Pipeline
  • News
  • Talent
  • Contact
中
  • Industry Trends
  • Technological Frontier
  • Information of YuanVore
Location: Home > News > Industry Trends
  • Human amniotic mesenchymal stem cells: An emerging force in the treatment of multi-system diseases.
    15
    2024-12
    2024-12-15
    In the vast field of medical research, human amniotic mesenchymal stem cells (hAMSC) are gradually coming into prominence.
  • To cure diseases, we must cure the root cause, and the root cause lies in the cells; if the cells are broken, use cells to repair them to protect health more efficiently!
    13
    2024-12
    2024-12-13
    Human body: A living body composed of approximately 40 trillion cells
  • The approved list will be released in three times! A total of 23 military hospitals have been approved as stem cell clinical research filing institutions!
    11
    2024-12
    2024-12-11
    A total of 23 military hospitals have been approved as stem cell clinical research filing institutions!
  • 2024 China Stem Cell Industry Market Research Report
    09
    2024-12
    2024-12-09
    2024 China Stem Cell Industry Market Research Report
  • National Development and Reform Commission: Encourage the development of cell industry!
    04
    2024-12
    2024-12-04
    Among the encouraged categories, cell culture, cell therapy drugs, and high-end intelligent pharmaceutical equipment are included in the list of encouraged industries.
  • Research progress and innovative strategies in induced pluripotent stem cell-derived mesenchymal stem cell therapy (3)
    26
    2024-11
    2024-11-26
    iPSC-MSC is the product with the most potential to replace adult MSC.
  • Research progress and innovative strategies in induced pluripotent stem cell-derived mesenchymal stem cell therapy (2)
    22
    2024-11
    2024-11-22
    iPSC-MSC is the product with the most potential to replace adult MSC.
  • Research progress and innovative strategies in induced pluripotent stem cell-derived mesenchymal stem cell therapy (1)
    21
    2024-11
    2024-11-21
    iPSC-MSC is the product with the most potential to replace adult MSC.
Prev
2 3 4 5 6 ...
Next
logo

Phone:021-64051958

Email:info@yuanvore.com

  • Cognition
    Cognition
    CellBank
    Platform
    Patent
  • Pipeline
    PipelineLayout
  • News
    Industry Trends
    Technological Frontier
    Information of YuanVore
  • Talent
    Enterprise Culture
    Job Information
  • About Us
    Contact Us
CopyRight @ 2023 Shanghai Yuanvore Medicine Technology Co., Ltd. AIl Rights Reserved 沪ICP备2023021701号

沪公网安备31011202020042号